The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Herbalife Ltd

NYSE: HLF
Last

(U.S.) $44.50

Today's change+1.08 +2.49%
Updated February 9 3:39 PM EST. Delayed by at least 15 minutes.
 

Herbalife Ltd

NYSE: HLF
Last

(U.S.) $44.50

Today's change+1.08 +2.49%
Updated February 9 3:39 PM EST. Delayed by at least 15 minutes.

Herbalife Ltd up sharply

Herbalife Ltd is up sharply today, rallying (U.S.)$1.08 or 2.49% to (U.S.)$44.50. Over the last five days, shares have lost 5.98% and are down 17.01% for the last year to date. This security has outperformed the S&P 500 by 35.79% during the last year.

Key company metrics

  • Open(U.S.) $42.78
  • Previous close(U.S.) $43.42
  • High(U.S.) $44.70
  • Low(U.S.) $42.52
  • Bid / Ask(U.S.) $44.50 / (U.S.) $44.52
  • YTD % change-17.01%
  • Volume1,986,265
  • Average volume (10-day)1,472,799
  • Average volume (1-month)1,709,776
  • Average volume (3-month)1,284,147
  • 52-week range(U.S.) $30.27 to (U.S.) $61.95
  • Beta1.48
  • Trailing P/E10.60×
  • P/E 1 year forward9.09×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $4.20
Updated February 9 3:39 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+7.95%

Based on its net profit margin of 7.95%, Herbalife Ltd is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.09%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue1,1031,1621,1051,134
Total other revenue--------
Total revenue1,1031,1621,1051,134
Gross profit896933890914
Total cost of revenue207229215220
Total operating expense9411,019970972
Selling / general / administrative729789748749
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income162144136162
Interest income (expense), net non-operating-26-25-23-26
Gain (loss) on sale of assets--------
Other--------
Income before tax138120112139
Income after tax948378103
Income tax, total44373436
Net income948378103
Total adjustments to net income--------
Net income before extra. items948378103
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items948378103
Inc. avail. to common incl. extra. items948378103
Diluted net income948378103
Dilution adjustment--0----
Diluted weighted average shares86858585
Diluted EPS excluding extraordinary itemsvalue per share1.090.970.921.21
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.090.970.921.21